This paper attempts to evaluate the possible gains and losses arising from the gradual opening up of pharmaceutical trade between India and Pakistan. We explain the comparative advantages of both countries at a disaggregated level, followed by a qualitative analysis of various perceptions and...

A major producer and exporter of formulated, low-cost generic pharmaceuticals, India increased its exports to major markets during 2011–17, including sub-Saharan Africa (SSA) and the United States. India is also taking steps to produce more innovative pharmaceuticals through such measures as...

In 2005, as the result of a World Trade Organization mandate, India began to implement product patents for pharmaceuticals that were compliant with the 1995 Trade-Related Aspects of Intellectual Property Rights (TRIPS). We combine pharmaceutical product sales data for India with a newly gathered...

Novartis spent nearly 15 years seeking a patent in India for Glivec. That quest reached its dead end, at last, on April 1st. India's Supreme Court rejected the Swiss drugmaker's patent. It represents critical issues related to intellectual property protection and access to medicines, which will...